By analysing the overall survival of the chosen CRC patients, we found that patients with high CD163 levels (IHC score 6−12) had poorer survival than patients with low CD163 levels (IHC score 0–4) (Figure 1E). Here, CD163 is linked to colorectal carcinoma.